TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 90nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1/N-type calcium channel subunit alpha-1B/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 220nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 230nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 240nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 240nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 270nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 280nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 280nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 310nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 340nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 380nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 460nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 510nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 510nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 610nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 690nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.03E+3nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.25E+3nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair